Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
53
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Hai Liu1 Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, People’s Republic of China
,
Weifang Yang2 Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, People’s Republic of China
,
Huaping Gao3 Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Tingting Jiang1 Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, People’s Republic of China
,
Bengxin Gu1 Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, People’s Republic of China
,
Qinghua Dong4 Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Wenhong Xu5 Department of Radiation Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, People’s Republic of China
,
Shixiu Wu6 Department of Radiation Oncology, Hangzhou Cancer Hospital, Wushan District, Hangzhou First People’s Hospital, Hangzhou, People’s Republic of China
&
Xiaonan Sun1 Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 509-518 | Published online: 25 Feb 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.